Retatrutide is a novel glucagon-like peptide-1 receptor agonist. This drug has shown efficacy in controlling type 2 diabetes. By mimicking the actions of naturally occurring GLP-1, Retatrutide boosts insulin secretion https://elodiebrfl892513.blog5.net/86371570/retatride-a-novel-glucagon-like-peptide-1-receptor-agonist